Clinical Trials Logo

Filter by:
NCT ID: NCT05098080 Active, not recruiting - Pharmacokinetics Clinical Trials

Hutrukin to Analyze Safety and PK in Healthy Volunteers

Start date: April 10, 2023
Phase: Phase 1
Study type: Interventional

The study will be a Phase I, open label, safety and pharmacokinetics study of HutrukinTM in at least eight healthy subjects in each of the three dose cohorts (1,000 mg, 3,000 mg and 5,000 mg).

NCT ID: NCT05756699 Active, not recruiting - Liver Cirrhosis Clinical Trials

Evaluation of Proteome Multimarker Panel With Multiple Reaction Monitoring as a Surveillance for Hepatocellular Carcinoma

Start date: April 10, 2023
Phase:
Study type: Observational

Most current guidelines recommend hepatocellular carcinoma (HCC) surveillance with ultrasound and alpha feto-protein (AFP) every 6 months for individuals with risk factors. However, the sensitivity of ultrasound for HCC detection is significantly reduced, especially in high-risk cirrhotic patients. In this study, the investigators aim to evaluate the efficacy of multiple reaction monitoring (MRM)-based multimarker panel as a surveillance tool for HCC. During two surveillance periods (starting from the time of voluntary consent and 6 months later), participants receive ultrasound, AFP, and MRM-based multimarker panel analysis. Patients who are suspected of HCC based on one of three tests undergo a contrast-enhanced CT scan within 6 weeks. After 6 months from the second surveillance period, the investigators re-evaluate the development of HCC using contrast-enhanced CT and AFP. The diagnostic accuracy of MRM-based multimarker panel is compared to ultrasound and AFP.

NCT ID: NCT05781542 Active, not recruiting - HIV Infections Clinical Trials

Clinical Trial to Evaluate the Safety and Immunogenicity of Synthetic DNAs Encoding NP-GT8 and IL-12, With or Without a TLR-agonist-Adjuvanted HIV Env Trimer 4571 Boost, in Adults Without HIV

Start date: April 10, 2023
Phase: Phase 1
Study type: Interventional

This is an open-label study to examine the safety and immunogenicity of synthetic DNAs encoding NP-GT8 and IL-12 with or without a TLR-agonist-adjuvanted Env Trimer 4571 boost in adults without HIV. The primary hypothesis is that vaccination with a recombinant DNA vaccine encoding a germline-targeting epitope followed by a trimeric protein boost will be safe and immunogenic.

NCT ID: NCT05812443 Active, not recruiting - Quality of Life Clinical Trials

Assessment of Sleep Quality and Mental Health After Using Meditation

Start date: April 10, 2023
Phase: N/A
Study type: Interventional

This is a randomized controlled trial that intends to verify the effectiveness of the daily practice of meditation before going to sleep for the improvement of sleep, stress, mental health and quality of life of people with sleep problems.

NCT ID: NCT05814562 Active, not recruiting - Hypertension Clinical Trials

Cardiovascular Precision Medicine & Remote Intervention

CP&R
Start date: April 10, 2023
Phase: N/A
Study type: Interventional

This exploratory / proof of concept study aims to evaluate whether it is possible to identify at-risk patients based on EHR review of blood pressure fluctuation over time and cholesterol levels, recruit those patients, and engage them in a remote intervention protocol.

NCT ID: NCT05818423 Active, not recruiting - Clinical trials for Mild Cognitive Impairment

Brain Health Together: A Live-Streaming Group-Based Digital Program

Start date: April 10, 2023
Phase: N/A
Study type: Interventional

The purpose of this study is to develop and test a comprehensive Brain Health Together program for older adults living with cognitive decline.

NCT ID: NCT05825248 Active, not recruiting - Developmental Delay Clinical Trials

Comparing Two Protocols to Improve Reflex Integration and Functional Performance

Start date: April 10, 2023
Phase: N/A
Study type: Interventional

The goal of this quantitative experimental study is to compare two occupational therapy interventions intended to improve functional skills. The main questions it aims to answer are: Question 1: Do preschool children who participate in occupational therapy intervention designed to promote integration of the TLR reflex in conjunction with fine and gross motor intervention demonstrate improved integration of the TLR reflex in clinical assessment, compared to children who participate in fine and gross motor intervention only for an equal amount of time? Question 2: Do preschool children who participate in occupational therapy intervention designed to promote integration of the TLR reflex in conjunction with fine and gross motor intervention demonstrate improved integration of the TLR reflex in clinical assessment, compared to children who participate in fine and gross motor intervention only for an equal amount of time? Participants will participate in either a therapy program consisting of either fine and gross motor treatment in conjunction with reflex integration treatment, or fine and gross motor treatment only. If there is a comparison group: Researchers will compare the group recieving reflex integration in conjunction with fine and gross motor treatment and the fine and gross motor only group to see if one is more effective at integrating the reflex and/or improving functional skills.

NCT ID: NCT05860127 Active, not recruiting - Dementia Clinical Trials

Cognitive Stimulation Therapy for Dementia: A Two-Armed Pragmatic Trial

Start date: April 10, 2023
Phase: N/A
Study type: Interventional

Cognitive Stimulation Therapy (CST) is an evidence-based non-pharmacological group therapy shown to benefit people with mild to moderate dementia. Despite increasing availability of CST worldwide, access remains limited in the United States. This pilot pragmatic trial will embed CST referral into the standard care protocol of health care settings that serve people living with dementia in the state of Connecticut, and evaluate online delivery of CST known as virtual CST (V-CST), and assess the acceptability of V-CST to people living with dementia. The study design is a two-armed randomized embedded pragmatic clinical trial (ePCT). The trial aims to determine if cognitive decline is experienced less commonly among V-CST participants than control group members based on three widely used measures of cognition, the Montreal Cognitive Assessment (MoCA), St. Louis University Memory Screen (SLUMS), and Mini Mental State Exam (MMSE). The study population will be persons with mild to moderate dementia identified by clinicians in standard care. From this population, subject participants will be randomized to intervention and control groups. Patients randomly assigned to the intervention group will be referred by their clinical providers to participate in V-CST, and those who accept the referral will participate in the intervention.

NCT ID: NCT06054152 Active, not recruiting - Clinical trials for Non-small Cell Lung Cancer

CX3CR1+T Cell Predict Immunotherapy Efficacy

Start date: April 10, 2023
Phase:
Study type: Observational

This study aimed to evaluate the correlation between the proportion of flow-sorted CX3CR1+T cells in peripheral blood and the CX3CR1+T-specific gene signature and the efficacy of immunotherapy.

NCT ID: NCT06048809 Active, not recruiting - Oral Health Clinical Trials

A Study to Evaluate the Effect of a Stannous Fluoride Toothpaste on the Oral Microbiome

Start date: April 10, 2024
Phase: N/A
Study type: Interventional

The aim of this study is to evaluate the effect of a toothpaste containing stannous fluoride (SnF2) over time on the oral bacterial composition and activity and to explore its effect in comparison to a regular fluoride toothpaste.